Osterweis Strategic Income (OSTIX)
Nasdaq • Currently unchanged in today's trading session
1 member of Congress has disclosed 1 trade in Osterweis Strategic Income (OSTIX) via STOCK Act filings. The most recent disclosure was a sale by David B. McKinley on 4 May 2015. Aggregate disclosed activity totals roughly $175K in sales (midpoint estimates from bracketed disclosure amounts).
Osterweis Strategic Income is currently trading at $10.95, positioned at 11% of its 52-week range ($10.91 – $11.28).
Want to automatically copy Pelosi trades?
Mirror Nancy Pelosi's portfolio with just one click on eToro.
Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.
Past Performance is not an indication of future results.
Osterweis Strategic Income Price History and Technical Analysis
Congressional Trading Activity for OSTIX
| David B. McKinley | 4 May 2015 | 13 May 2016 | Sale | Stock | $100,001 - $250,000 | N/A |
Select transactions to view their annotations on the chart
Similar Stocks
Based on congressional trading patterns
Frequently Asked Questions about OSTIX
- Which members of Congress have traded OSTIX?
- 1 member of Congress has disclosed 1 trade in Osterweis Strategic Income (OSTIX) under the STOCK Act: David B. McKinley.
- When was OSTIX most recently disclosed by Congress?
- The most recent OSTIX disclosure was a sale by David B. McKinley on 4 May 2015.
- What is the total disclosed congressional trading volume for OSTIX?
- Members of Congress have disclosed approximately $175K in OSTIX sales (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
- How can I track new congressional trades in OSTIX?
- This OSTIX page updates as soon as new STOCK Act disclosures are filed for Osterweis Strategic Income. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Track OSTIX in Congress
See when politicians buy or sell this stock